Efficacy of Sameerapannaga Rasa in Tamaka Shwasa(bronchial Asthma)

Pharmaceutical standardization of Sameerapannaga Rasa prepared with and without Manahshila and their comparative clinical efficacy in Tamaka Shwasa (Bronchial asthma).

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066199

Enrollment

Registered

2024-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1Both the sexes having age between 18 years to 60 years. 2Patient having at least 3 symptoms (Wheeze, Cough and Breathlessness) of Tamaka Shwasa. 3Uncomplicated cases of Tamaka Shwasa

Exclusion criteria

Exclusion criteria: 1)Age below 18 years and above 60 years 2)Pregnant and lactating women 3)Patients having complications like 1 cor-pulmonale 2 pulmonary TB 3 emphysema 4 pneumonia 5 cystic fibrosis malignancy 7 severe anaemia 8 renal failure 9 congestive cardiac failure. 10 Patients suffering from malignant and accelerated hypertension 11 coronary artery disease

Design outcomes

Primary

Measure	Time frame
Improvement in cardinal symptoms like breathlessness, wheezingTimepoint: Baseline, From 1st week to 8 weeks weekly	—

Secondary

Measure	Time frame
Improvement in Pulmonanary Function test, ACQ, ACT scores Timepoint: 60 days	—

Countries

India

Contacts

Public ContactProf BJ Patgiri

Institute of Teaching and Research in ayurveda

patgiri124@gmail.com9426947438

Outcome results